These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25374210)

  • 1. Pharmacoeconomics evaluation of morphine, MS contin and oxycodone in the treatment of cancer pain.
    Zhang WZ; Yu WJ; Zhao XL; He BX
    Asian Pac J Cancer Prev; 2014; 15(20):8797-800. PubMed ID: 25374210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphine or oxycodone tablets for pain?].
    Fredheim OM; Dale O; Kaasa S; Borchgrevink PC
    Tidsskr Nor Laegeforen; 2010 Aug; 130(15):1479-81. PubMed ID: 20706310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Oxycodone versus Intravenous Morphine in Cancer Pain: A Randomized, Open-Label, Parallel-Group, Active-Control Study.
    Lee KH; Kang JH; Oh HS; Choi MK; Shim BY; Eum YJ; Park HJ; Kang JH
    Pain Res Manag; 2017; 2017():9741729. PubMed ID: 29670416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
    Miner JR; Moore J; Gray RO; Skinner L; Biros MH
    Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial.
    Narabayashi M; Saijo Y; Takenoshita S; Chida M; Shimoyama N; Miura T; Tani K; Nishimura K; Onozawa Y; Hosokawa T; Kamoto T; Tsushima T;
    Jpn J Clin Oncol; 2008 Apr; 38(4):296-304. PubMed ID: 18326541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost-effective analysis of rotation from sustained-release morphine tablet to transdermal fentanyl of matrix type or sustained-release oxycodone tablet].
    Ise Y; Wako T; Miura Y; Katayama S; Shimizu H
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2599-603. PubMed ID: 20009462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy switching in patients receiving long-acting opioids.
    Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
    Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Tolerability Profile of Controlled-Release Oral Morphine and Oxycodone for Cancer Pain Treatment. An Open-Label Randomized Controlled Trial.
    Zecca E; Brunelli C; Bracchi P; Biancofiore G; De Sangro C; Bortolussi R; Montanari L; Maltoni M; Moro C; Colonna U; Finco G; Roy MT; Ferrari V; Alabiso O; Rosti G; Kaasa S; Caraceni A
    J Pain Symptom Manage; 2016 Dec; 52(6):783-794.e6. PubMed ID: 27742577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion ratio and cost of oxycodone.
    Kwarcinski M
    Am J Hosp Palliat Care; 2001; 18(3):159-60. PubMed ID: 11406890
    [No Abstract]   [Full Text] [Related]  

  • 10. Analgesic efficacy and tolerability of intravenous morphine versus combined intravenous morphine and oxycodone in a 2-center, randomized, double-blind, pilot trial of patients with moderate to severe pain after total hip replacement.
    Joppich R; Richards P; Kelen R; Stern W; Zarghooni K; Otto C; Böhmer A; Petzke F; Treptau T; Lefering R; Bäthis H; Neugebauer E
    Clin Ther; 2012 Aug; 34(8):1751-60. PubMed ID: 22795613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of OROS hydromorphone for chronic pain: a Pan-European perspective.
    Hauber AB; Fleischmann J; Lothgren M; Wilson M; Lam A; Dubois D; Sabatowski R
    J Opioid Manag; 2011; 7(4):287-96. PubMed ID: 21957828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
    Bruera E; Belzile M; Pituskin E; Fainsinger R; Darke A; Harsanyi Z; Babul N; Ford I
    J Clin Oncol; 1998 Oct; 16(10):3222-9. PubMed ID: 9779695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial.
    Moksnes K; Dale O; Rosland JH; Paulsen O; Klepstad P; Kaasa S
    Eur J Cancer; 2011 Nov; 47(16):2463-70. PubMed ID: 21775131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sustained-release Opioids: Morphine, Oxycodone and Tapentadol].
    Takahashi Y; Iseki M
    Masui; 2015 Nov; 64(11):1133-40. PubMed ID: 26689063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: a pilot study.
    Sloan P; Slatkin N; Ahdieh H
    Support Care Cancer; 2005 Jan; 13(1):57-65. PubMed ID: 15538638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New option in the management of cancer pain in Hungary: short acting oral opioid therapy].
    Kullmann T; Sipőcz I; Csikós Á; Pintér T
    Orv Hetil; 2015 Jun; 156(25):1003-6. PubMed ID: 26170088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral oxycodone for pain after caesarean section: A randomized comparison with nurse-administered IV morphine in a pragmatic study.
    Niklasson B; Arnelo C; Öhman SG; Segerdahl M; Blanck A
    Scand J Pain; 2015 Apr; 7(1):17-24. PubMed ID: 29911601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid-Induced Constipation Relief From Fixed-Ratio Combination Prolonged-Release Oxycodone/Naloxone Compared With Oxycodone and Morphine for Chronic Nonmalignant Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Huang L; Zhou JG; Zhang Y; Wang F; Wang Y; Liu DH; Li XJ; Lv SP; Jin SH; Bai YJ; Ma H
    J Pain Symptom Manage; 2017 Nov; 54(5):737-748.e3. PubMed ID: 28736104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of daily average consumption (DACON) of oxycodone and oxymorphone long-acting oral tablets.
    Rubino M; Summers KH; Puenpatom A; Fu C; Ohsfeldt RL; Ben-Joseph RH
    J Manag Care Pharm; 2011 Jun; 17(5):367-76. PubMed ID: 21657806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of serum albumin levels during opioid rotation from morphine or oxycodone to fentanyl for cancer pain.
    Hayashi T; Ikehata S; Matsuzaki H; Yasuda K; Makihara T; Futamura A; Arakawa Y; Kuki R; Fukuura K; Takahashi H; Mori N; Higashiguchi T; Yamadaa S
    Biol Pharm Bull; 2014; 37(12):1860-5. PubMed ID: 25590058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.